A major study in The Lancet Infectious Diseases confirms that single low-dose primaquine is safe and effective in reducing malaria transmission in young children. Analysing data from over 6,000 patients, researchers found it effective even in young children and areas with high malaria burden. The findings support expanding primaquine use to tackle drug-resistant malaria in Africa. A child-friendly formulation is urgently needed to maximise its impact on malaria elimination efforts worldwide.
The climate crisis is a health emergency which is threatening the lives and wellbeing of communities around the world in many ways \u2013 including through air pollution, rising temperatures, the spread of infectious diseases and antimicrobial resistance.
Results of two parallel studies show that one in four African children hospitalised with malaria and coma have an additional infection, and that giving antibiotics with antimalarials could help reduce death rates of comatose children.
Professor Christine Gerrard, Director of The Oxford Research Centre in the Humanities (TORCH) and Professor of eighteenth-century literature and culture, explores interdisciplinary research as a 'magic bullet' to tackle major global challenges such as the climate crisis, democratic stability and global health inequity.
Oxford experts estimate that 1 million additional children could become infected with HIV and nearly 500,000 children could die from AIDS by 2030, while as many as 2.8 million children could become orphaned in the next five years if US President\u2019s Emergency Plan for AIDS Relief (PEPFAR) programmes are reduced or eliminated.
Researchers from the Nuffield Department of Primary Care Health Sciences are part of a major new research initiative aimed at tackling critical workforce challenges in healthcare, particularly in underserved communities.
The world is facing a shortage of 11 million health workers by 2030. World Health Worker Week calls for increased investment in all cadres of the health workforce - nurses, doctors, pharmacists, and others vital to resilient health systems. Health workers save lives, support economies, and advance development goals. Collaborative efforts, such as OUCRU\u2019s training programme in Dak Lak, Vietnam, demonstrate the benefits of investment, with increased vaccine uptake. Protecting, valuing, and training health workers strengthens global health.
The Kenya Medical Research Institute (KEMRI) has officially entered into a seven-year Memorandum of Understanding (MoU) with Wellcome, a UK-based charitable foundation, and the University of Oxford. The \u00a391 million agreement was signed at the Wellcome headquarters in London, marking a significant boost for medical research and training in Kenya.
The Jenner Institute, in partnership with the Coler Lab at Seattle Children\u2019s Research Institute (SCRI), is set to begin a new clinical trial to test tuberculosis (TB) vaccine safety and the host immune response in a first-in-man aerosol mycobacterial challenge infection model with healthy adult volunteers.
By 2050, Africa will host a majority of the world's student-age population, shaping global futures. The Mastercard Foundation Scholars at Oxford's Africa Oxford Initiative receive full scholarships, rigorous education, leadership training, entrepreneurship support and networking, preparing them to lead Africa's and the world's future challenges and opportunities.
A survey at Vietnam's National Hospital for Tropical Diseases found 60% of hepatitis C patients unaware of how they contracted the disease, often diagnosed late. Globally, viral hepatitis causes 3,500 daily deaths, ranking second among infectious killers after tuberculosis.
A landmark study involving researchers from NDM\u2019s Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.
The chapel facade of Magdalen College was lit up ahead of the commemoration of Rare Disease Day (RDD) which was celebrated on Friday 28th February 2025. The celebration is held on 29th February in a leap year as it is the rarest day in the year.
A new analysis by researchers at Oxford Population Health\u2019s Infectious Disease Epidemiology Unit has provided robust evidence in support of current World Health Organization (WHO) guidelines for treating pregnant women living with HIV. The study is published in Clinical Microbiology and Infection.
The Ineos Oxford Institute for antimicrobial research (IOI) has awarded \u00a35 million to a group of 17 interdisciplinary researchers from Oxford University to develop new therapies for drug-resistant tuberculosis.
After more than a year of community engagement and preparation in 100 villages with 12,000 populations across the Chittagong Hill Tracts, the mass malaria vaccine (R21/Matrix M) and drug (DHA, piperaquine, and single low dose primaquine) administration study started on 15 Feb.
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
![\"Woman](\"https://www.globalhealth.ox.ac.uk/news/new-study-confirms-malaria-drug-is-safe-for-children-and-could-reduce-disease-spread/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n